12
Participants
Start Date
August 31, 2024
Primary Completion Date
August 31, 2025
Study Completion Date
August 31, 2025
Dapagliflozin tablet
"Patients randomized to Group A will start with Dapagliflozin on Visit 1 and take Dapagliflozin once daily up to the day before Visit 3.~Patients randomized to Group B will start Dapagliflozin once daily on the day of Visit 3, to be continued up to the day preceding Visit 4.~Dose:~* participants ≤12 year old: 5mg once daily p.o. (commercially available tablet)~* participants \>12 year old: 10mg once daily p.o. (commercially available tablet)"
Empagliflozin Tablets
"Patients randomized to Group A will start with Empagliflozin on Visit 1 and take Empagliflozin once daily up to the day before Visit 3.~Patients randomized to Group B will start Empagliflozin once daily on the day of Visit 3, to be continued up to the day preceding Visit 4.~Dose: Empagliflozin 10mg once daily p.o. (commercially available tablet)"
Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne
University College London, London
Great Ormond Street Hospital NHS Foundation Trust, London
Great Ormond Street Hospital for Children NHS Foundation Trust
OTHER
University College, London
OTHER
Centre Hospitalier Universitaire Vaudois
OTHER